This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Amgen Inc., Ucb Pharma, S.a., Ucb S.a.. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Slough, GB (2009)
- Berkshire, GB (2011)
Company Filing History:
2 out of 2,074 
1 out of 180 
1 out of 119 
Years Active: 2009-2011
Title: The Innovations of Andy Popplewell
Introduction
Andy Popplewell is a notable inventor based in Berkshire, GB. He has made significant contributions to the field of biotechnology, particularly in the development of sclerostin-binding antibodies. With a total of 2 patents to his name, his work has implications for various therapeutic applications.
Latest Patents
Popplewell's latest patents include compositions and methods relating to epitopes of the sclerostin protein. His patents focus on sclerostin-binding agents, such as antibodies capable of binding to sclerostin. These innovations are crucial for advancing research in bone metabolism and related disorders.
Career Highlights
Throughout his career, Andy Popplewell has worked with prominent companies in the biotechnology sector, including Amgen Inc. and UCB S.A. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Christopher J. Paszty and Martyn Kim Robinson. Their collaborative efforts have further enhanced the impact of Popplewell's inventions in the scientific community.
Conclusion
Andy Popplewell's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile